Erratum to: Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation: Salmonella -induced upregulation of Cx43 (International Journal of Cancer, (2013), 133, 8, (1926-1935), 10.1002/ijc.28155);Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation

International Journal of Cancer

Volumn 133, Issue 8, 2013, Pages 1926-1935

  Chang, Wen Wei ^a,b   Lai, Chih Ho ^c   Chen, Man Chin ^c   Liu, Chi Fan ^c   Kuan, Yu Diao ^c   Lin, Song Tao ^c   Lee, Che Hsin ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cisplatin; connexin 43; gap junctions; Salmonella; tumor

Indexed keywords

CISPLATIN; CONNEXIN 43; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL DEATH; CONTROLLED STUDY; DRUG SENSITIVITY; GAP JUNCTION; LOW DRUG DOSE; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR REGRESSION; UPREGULATION;

EID: 84881543912     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30693     Document Type: Erratum

References (36)

1. Liu F, Zhang L, Hoffman RM, et al. Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 2010; 9: 4518-24.
2. Nagakura C, Hayashi K, Zhao M, et al. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009; 29: 1873-78.
3. Yam C, Zhao M, Hayashi K, et al. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 2010; 164: 248-255.
4. Hayashi K, Zhao M, Yamauchi K, et al. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 2009; 8: 870-75.
5. Kimura H, Zhang L, Zhao M, et al. Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 2010; 43: 41-8.
6. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Hoffman RM,. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009; 106: 992-8.
7. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman R,. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007; 104: 10170-74.
8. Zhao M, Yang M, Ma H, et al. Targeted therapy with a Salmonella typhimurium leucine-Arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006; 66: 7647-52.
9. Sharrow AC, Li Y, Micsenyi A, et al. Modulation of osteoblast gap junction connectivity by serum, TNF-α, and TRAIL. Exp Cell Res 2008; 314: 297-308.
10. Wang M, Berthoud VM, Beyer EC,. Connexin43 increases the sensitivity of prostate cancer cells to TNF-α-induced apoptosis. J Cell Sci 2007; 120: 320-29.
11. Mancuso M, Pasquali E, Leonardi S, et al. Role of connexin43 and ATP in long-range bystander radiation damage and oncogenesis in vivo. Oncogene 2011; 30: 4601-08.
12. Saccheri F, Pozzi C, Avogadri F, et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2010; 2: 44ra57.
13. Lee CH, Wu CL, Tai YS, et al. Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 2005; 11: 707-16.
14. Lee CH, Wu CL, Shiau AL,. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J Gene Med 2004; 6: 1382-93.
15. Wang SW, Wu HH, Liu SC, et al. CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS One 2012; 7: e35101.
16. Lin HY, Tang CH, Chen JH, et al. Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun, and AP-1 pathways in microglia. J Cell Physiol 2011; 226: 1573-82.
17. Tang CH, Yang RS, Chien MY, et al. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur J Pharmacol 2008; 579: 40-9.
18. Lee CH, Wu CL, Shiau AL,. Toll-like receptor 4 signaling promotes tumor growth. J Immunother 2010; 33: 73-82.
19. Lee CH, Wu CL, Shiau AL,. Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma. Int J Cancer 2008; 122: 930-5.
20. Bhattacharjee R, Kaneda M, Nakahama K, et al. The steady-state expression of connexin43 is maintained by the PI3K/Akt in osteoblasts. Biochem Biophys Res Commun 2009; 382: 440-4.
21. Crespin S, Bechberger J, Mesnil M, et al. The carboxy-terminal tail of connexin 43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells. J Cell Biochem 2010; 110: 589-97.
22. Behrens J, Kameritsch P, Wallner S, et al. The carboxyl tail of Cx43 augments p38 mediated cell migration in a gap junction-independent manner. Eur J Cell Biol 2010; 89: 828-38.
23. Pawelek JM, Low KB, Bermudes D,. Bacteria as tumour-targeting vectors. Lancet Oncol 2003; 4: 548-56.
24. Pawelek JM, Low KB, Bermudes D,. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997; 57: 4537-44.
25. Cottin S, Gould PV, Cantin L, et al. Gap junctions in human glioblastomas: implications for suicide gene therapy. Cancer Gene Ther 2011; 18: 674-81.
26. Jia G, Cheng G, Gangahar DM, et al. (2008) Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol 2008; 44: 882-90.
27. Robertson J, Lang S, Lambert PA, et al. Peptidoglycan derived from Staphyococcus epidermidis induces connexin 43 hemichannel activity with consequences on the innate immune response in endothelial cells. Biochem J 2010; 432: 133-43.
28. Lee CH,. Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives. Appl Microbiol Biotechnol 2012; 93: 517-23.
29. Lee CH, Wu CL, Shiau AL,. Hypoxia-induced cytosine deaminase gene expression for cancer therapy. Hum Gene Ther 2007; 18: 27-38.
30. Peixoto PM, Ryu SY, Pruzansky DP, et al. Mitochondrial apoptosis is amplified through gap junctions. Biochem Biophys Res Commun 2009; 390: 38-43.
31. Azzam EI, de Toledo AM, Little JB,. Expression of connexin 43 is highly sensitive to ionizing radiation and other environmental stresses. Cancer Res 2003; 63: 7128-35.
32. Lee CH, Hsieh JL, Wu CL, et al. T cell augments the antitumor activity of tumor-targeting Salmonella. Appl Microbiol Biotechnol 2011; 90: 1381-88.
33. Avogadri F, Martinoli C, Petrovska L, et al. Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res 2005; 65: 3920-7.
34. Lee CH, Wu CL, Shiau AL,. (2008) Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis. Clin Cancer Res 2008; 14: 1905-12.
35. Lee CH, Hsieh JL, Wu CL, et al. B cells are required for tumor-targeting Salmonella in host. Appl Microbiol Biotechnol 2011; 92: 1251-60.
36. Lee CH, Lin YH, Hsieh JL, et al. A polymer coating applied to Salmonella prevents the binding of Salmonella-specific antibodies. Int J Cancer 2013; 132: 717-25.